Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.680
-0.410 (-10.02%)
At close: May 13, 2026, 4:00 PM EDT
3.820
+0.140 (3.80%)
After-hours: May 13, 2026, 7:11 PM EDT

Ironwood Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6065507101,7891,9081,889
Market Cap Growth
285.60%-22.57%-60.32%-6.27%1.01%3.28%
Enterprise Value
982.66728.921,2172,2091,6651,625
Last Close Price
3.683.374.4311.4412.3911.66
PE Ratio
5.9622.47443.00-1.7712.913.63
Forward PE
3.267.8413.4214.1411.248.43
PEG Ratio
---1.982.251.21
PS Ratio
1.681.862.024.044.654.57
PB Ratio
--2.10-2.36-5.172.933.12
P/TBV Ratio
-2.90-2.10-2.35-5.133.543.16
P/FCF Ratio
5.404.336.869.776.977.22
P/OCF Ratio
5.404.336.859.756.977.21
EV/Sales Ratio
2.722.463.464.994.063.93
EV/EBITDA Ratio
4.827.2612.80-2.346.616.95
EV/EBIT Ratio
4.867.4013.07-2.346.657.00
EV/FCF Ratio
8.765.7411.7712.066.096.21
Debt / Equity Ratio
-1.82-1.51-1.98-1.480.630.59
Debt / EBITDA Ratio
2.965.966.30-0.761.652.04
Debt / FCF Ratio
5.324.715.803.911.521.82
Net Debt / Equity Ratio
-1.74-1.46-1.70-1.80-0.37-0.24
Net Debt / EBITDA Ratio
1.873.815.37-0.66-0.95-0.62
Net Debt / FCF Ratio
3.363.014.943.40-0.88-0.55
Asset Turnover
0.870.790.860.560.370.49
Quick Ratio
1.381.084.390.8030.234.54
Current Ratio
1.411.134.690.8430.584.61
Return on Equity (ROE)
-100.53%-41.21%-40.00%-564.93%52.42%-38.03%
Return on Assets (ROA)
67.61%43.65%45.01%-109.72%29.37%-17.45%
Return on Invested Capital (ROIC)
174.00%88.50%69.52%-237.06%73.64%-46.42%
Return on Capital Employed (ROCE)
113.44%42.21%36.73%-148.89%24.54%31.13%
Earnings Yield
16.87%4.45%0.23%-56.38%7.75%27.53%
FCF Yield
18.52%23.11%14.57%10.24%14.34%13.85%
Buyback Yield / Dilution
-2.82%-1.81%-2.99%16.57%-13.32%-2.34%
Total Shareholder Return
-2.82%-1.81%-2.99%16.57%-13.32%-2.34%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q